1. Home
  2. ATYR vs MTRX Comparison

ATYR vs MTRX Comparison

Compare ATYR & MTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • MTRX
  • Stock Information
  • Founded
  • ATYR 2005
  • MTRX 1984
  • Country
  • ATYR United States
  • MTRX United States
  • Employees
  • ATYR N/A
  • MTRX N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • MTRX Engineering & Construction
  • Sector
  • ATYR Health Care
  • MTRX Consumer Discretionary
  • Exchange
  • ATYR Nasdaq
  • MTRX Nasdaq
  • Market Cap
  • ATYR 306.2M
  • MTRX 327.8M
  • IPO Year
  • ATYR 2015
  • MTRX 1990
  • Fundamental
  • Price
  • ATYR $4.57
  • MTRX $12.25
  • Analyst Decision
  • ATYR Strong Buy
  • MTRX Strong Buy
  • Analyst Count
  • ATYR 6
  • MTRX 1
  • Target Price
  • ATYR $18.60
  • MTRX $20.00
  • AVG Volume (30 Days)
  • ATYR 1.5M
  • MTRX 184.7K
  • Earning Date
  • ATYR 05-07-2025
  • MTRX 05-07-2025
  • Dividend Yield
  • ATYR N/A
  • MTRX N/A
  • EPS Growth
  • ATYR N/A
  • MTRX N/A
  • EPS
  • ATYR N/A
  • MTRX N/A
  • Revenue
  • ATYR N/A
  • MTRX $742,408,000.00
  • Revenue This Year
  • ATYR $1,264.26
  • MTRX $9.98
  • Revenue Next Year
  • ATYR $1,239.11
  • MTRX $20.42
  • P/E Ratio
  • ATYR N/A
  • MTRX N/A
  • Revenue Growth
  • ATYR N/A
  • MTRX N/A
  • 52 Week Low
  • ATYR $1.42
  • MTRX $8.61
  • 52 Week High
  • ATYR $4.66
  • MTRX $15.75
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 77.04
  • MTRX 47.99
  • Support Level
  • ATYR $4.16
  • MTRX $12.05
  • Resistance Level
  • ATYR $3.94
  • MTRX $12.58
  • Average True Range (ATR)
  • ATYR 0.30
  • MTRX 0.42
  • MACD
  • ATYR 0.13
  • MTRX -0.08
  • Stochastic Oscillator
  • ATYR 96.94
  • MTRX 24.27

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About MTRX Matrix Service Company

Matrix Service Co is an engineering and construction provider for large industrial projects, primarily in the oil and gas, power, petrochemical, industrial, mining, and minerals markets. It offers engineering, fabrication, construction, and maintenance services, operating across three segments namely Utility and Power Infrastructure; Process and Industrial Facilities; and Storage and Terminal Solutions.

Share on Social Networks: